Login Register Cart 0
Generic placeholder image

Current Pharmaceutical Biotechnology

Editor-in-Chief

ISSN (Print): 1389-2010
ISSN (Online): 1873-4316

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Mini-Review Article

Second-generation Liquid Platelet Concentrates: A Literature Review

Author(s): Rucha Shah*, Triveni M. Gowda, Raison Thomas and Tarun Kumar

Volume 23, Issue 11, 2022

Published on: 06 January, 2022

Page: [1315 - 1326] Pages: 12

DOI: 10.2174/1389201022666210823102618

Price: $65

Abstract

Liquid or injectable platelet-rich fibrin (PRF) is a second-generation platelet concentrate that is completely autologous and free of external additives, like bovine thrombin and calcium chloride. Additionally, it is the only one to be obtained in a liquid form among the second-generation platelet concentrates. This allows for wide applications such as maximizing injections or mixing with biomaterials such as bone grafts or antibiotics. Since it was first introduced in 2015, several modifications of the original protocol have been proposed which aim at maximizing its biological and mechanical properties. This includes changes in centrifugation speed, time, and so on. The aim of this review is to summarize the various modifications of the injectable/liquid formation of PRF as well as to discuss the potential applications and future research direction.

Keywords: Blood platelets, fibrin, growth factors, leukocytes, injectable platelet-rich fibrin, platelet concentrate.

« Previous Next »
Graphical Abstract

[1]
Dohan, D.M.; Choukroun, J.; Diss, A.; Dohan, S.L.; Dohan, A.J.; Mouhyi, J.; Gogly, B. Platelet-rich fibrin (PRF): a second-generation platelet concentrate. Part I: technological concepts and evolution. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod., 2006, 101(3), e37-e44.
[http://dx.doi.org/10.1016/j.tripleo.2005.07.008] [PMID: 16504849]
[2]
Choukroun, J.; Adda, F.; Schoeffler, C.; Vervelle, A. Une opportunity en paro-implantologie: Le PRF. Implantodontie, 2001, 42, 55-62.
[3]
Miron, R.J.; Fujioka-Kobayashi, M.; Hernandez, M.; Kandalam, U.; Zhang, Y.; Ghanaati, S.; Choukroun, J. Injectable platelet rich fibrin (i-PRF): opportunities in regenerative dentistry? Clin. Oral Investig., 2017, 21(8), 2619-2627.
[http://dx.doi.org/10.1007/s00784-017-2063-9] [PMID: 28154995]
[4]
Ghanaati, S.; Booms, P.; Orlowska, A.; Kubesch, A.; Lorenz, J.; Rutkowski, J.; Landes, C.; Sader, R.; Kirkpatrick, C.; Choukroun, J. Ad-vanced platelet-rich fibrin: a new concept for cell-based tissue engineering by means of inflammatory cells. J. Oral Implantol., 2014, 40(6), 679-689.
[http://dx.doi.org/10.1563/aaid-joi-D-14-00138] [PMID: 24945603]
[5]
Sohn, D-S.; Huang, B.; Kim, J.; Park, W.E.; Park, C.C. Utilization of autologous concentrated growth factors (CGF) enriched bone graft matrix (Sticky bone) and CGF-enriched fibrin membrane in Implant Dentistry. Jr Implant Adv Cli Dent, 2015, 7, 11-29.
[6]
Mourão, C.F.; Valiense, H.; Melo, E.R.; Mourão, N.B.; Maia, M.D. Obtention of injectable platelets rich-fibrin (i-PRF) and its polymeriza-tion with bone graft: technical note. Rev. Col. Bras. Cir., 2015, 42(6), 421-423.
[http://dx.doi.org/10.1590/0100-69912015006013] [PMID: 26814997]
[7]
Varela, H.A.; Souza, J.C.M.; Nascimento, R.M.; Araújo, R.F., Jr; Vasconcelos, R.C.; Cavalcante, R.S.; Guedes, P.M.; Araújo, A.A. Injecta-ble platelet rich fibrin: cell content, morphological, and protein characterization. Clin. Oral Investig., 2019, 23(3), 1309-1318.
[http://dx.doi.org/10.1007/s00784-018-2555-2] [PMID: 30003342]
[8]
Fujioka-Kobayashi, M.; Miron, R.J.; Hernandez, M.; Kandalam, U.; Zhang, Y.; Choukroun, J. Optimized platelet-rich fibrin with the low-speed concept: Growth factor release, biocompatibility, and cellular response. J. Periodontol., 2017, 88(1), 112-121.
[http://dx.doi.org/10.1902/jop.2016.160443] [PMID: 27587367]
[9]
Choukroun, J.; Ghanaati, S. Reduction of relative centrifugation force within injectable platelet-rich-fibrin (PRF) concentrates advances patients’ own inflammatory cells, platelets and growth factors: the first introduction to the low speed centrifugation concept. Eur. J. Trauma Emerg. Surg., 2018, 44(1), 87-95.
[http://dx.doi.org/10.1007/s00068-017-0767-9] [PMID: 28283682]
[10]
Bowen, R.A.R.; Remaley, A.T. Interferences from blood collection tube components on clinical chemistry assays., Biochem. Med. (Zagreb), 2014, 24(1), 31-44..
[http://dx.doi.org/10.11613/BM.2014.006] [PMID: 24627713]
[11]
Wend, S.; Kubesch, A.; Orlowska, A.; Al-Maawi, S.; Zender, N.; Dias, A.; Miron, R.J.; Sader, R.; Booms, P.; Kirkpatrick, C.J.; Choukroun, J.; Ghanaati, S. Reduction of the relative centrifugal force influences cell number and growth factor release within injectable PRF-based matrices. J. Mater. Sci. Mater. Med., 2017, 28(12), 188.
[http://dx.doi.org/10.1007/s10856-017-5992-6] [PMID: 29071440]
[12]
Miron, R.J.; Chai, J.; Zhang, P.; Li, Y.; Wang, Y.; Mourão, C.F.A.B.; Sculean, A.; Fujioka Kobayashi, M.; Zhang, Y. A novel method for harvesting concentrated platelet-rich fibrin (C-PRF) with a 10-fold increase in platelet and leukocyte yields. Clin. Oral Investig., 2020, 24(8), 2819-2828.
[http://dx.doi.org/10.1007/s00784-019-03147-w] [PMID: 31788748]
[13]
Fujioka-Kobayashi, M.; Katagiri, H.; Kono, M.; Schaller, B.; Zhang, Y.; Sculean, A.; Miron, R.J. Improved growth factor delivery and cellular activity using concentrated platelet-rich fibrin (C-PRF) when compared with traditional injectable (i-PRF) protocols. Clin. Oral Investig., 2020, 24(12), 4373-4383. [published online ahead of print, 2020 May 7
[http://dx.doi.org/10.1007/s00784-020-03303-7] [PMID: 32382929]
[14]
Miron, R.J.; Chai, J.; Fujioka-Kobayashi, M.; Sculean, A.; Zhang, Y. Evaluation of 24 protocols for the production of platelet-rich fibrin. BMC Oral Health, 2020, 20(1), 310.
[http://dx.doi.org/10.1186/s12903-020-01299-w] [PMID: 33160335]
[15]
Serafini, G.; Lopreiato, M.; Lollobrigida, M.; Lamazza, L.; Mazzucchi, G.; Fortunato, L.; Mariano, A.; Scotto d’Abusco, A.; Fontana, M.; De Biase, A. Platelet rich fibrin (PRF) and its related products: biomolecular characterization of the liquid fibrinogen. J. Clin. Med., 2020, 9(4), 1099.
[http://dx.doi.org/10.3390/jcm9041099] [PMID: 32290550]
[16]
Kızıltoprak, M.; Uslu, M.Ö. Comparison of the effects of injectable platelet-rich fibrin and autologous fibrin glue applications on palatal wound healing: a randomized controlled clinical trial. Clin. Oral Investig., 2020, 24(12), 4549-4561.
[http://dx.doi.org/10.1007/s00784-020-03320-6] [PMID: 32424462]
[17]
Zheng, S.; Zhang, X.; Zhao, Q.; Chai, J.; Zhang, Y. Liquid platelet-rich fibrin promotes the regenerative potential of human periodontal ligament cells. Oral Dis., 2020, 26(8), 1755-1763.
[http://dx.doi.org/10.1111/odi.13501] [PMID: 32564447]
[18]
Thanasrisuebwong, P.; Kiattavorncharoen, S.; Surarit, R.; Phruksaniyom, C.; Ruangsawasdi, N. Red and yellow injectable platelet-rich fibrin demonstrated differential effects on periodontal ligament stem cell proliferation, migration, and osteogenic differentiation. Int. J. Mol. Sci., 2020, 21(14), 5153.
[http://dx.doi.org/10.3390/ijms21145153] [PMID: 32708242]
[19]
Thanasrisuebwong, P.; Surarit, R.; Bencharit, S.; Ruangsawasdi, N. Influence of fractionation methods on physical and biological proper-ties of injectable platelet-rich fibrin: An exploratory study. Int. J. Mol. Sci., 2019, 20(7), 1657.
[http://dx.doi.org/10.3390/ijms20071657] [PMID: 30987117]
[20]
Fujioka-Kobayashi, M.; Schaller, B.; Mourão, C.F.A.B.; Zhang, Y.; Sculean, A.; Miron, R.J. Biological characterization of an injectable platelet-rich fibrin mixture consisting of autologous albumin gel and liquid platelet-rich fibrin (Alb-PRF). Platelets, 2021, 32(1), 74-81.
[http://dx.doi.org/10.1080/09537104.2020.1717455] [PMID: 31959025]
[21]
Barros Mourão, CF.; Gheno, E.; Lourenço, ES. Characterization of a new membrane from concentrated growth factors associated with dena-turized Albumin (Alb-CGF) for clinical applications: A preliminary study. Int J Growth Factors Stem Cells Dent, 2018, 1, 64-69.
[http://dx.doi.org/10.4103/GFSC.GFSC_21_18]
[22]
Gheno, E.; Mourão, C.F.A.B.; Mello-Machado, R.C.; Stellet Lourenço, E.; Miron, R.J.; Catarino, K.F.F.; Alves, A.T.; Alves, G.G. Ca-lasans-Maia, M.D. In vivo evaluation of the biocompatibility and biodegradation of a new denatured plasma membrane combined with liq-uid PRF (Alb-PRF). Platelets, 2020, 1-13.
[http://dx.doi.org/10.1080/09537104.2020.1775188] [PMID: 32531175]
[23]
Kargarpour, Z.; Nasirzade, J.; Panahipour, L.; Miron, RJ.; Gruber, R. Liquid platelet-rich fibrin and heat-coagulated albumin gel: bioassays for TGF-β activity. Materials (Basel), 2020, 13(16), E3466. [Published 2020 Aug 6
[http://dx.doi.org/10.3390/ma13163466]
[24]
Chandra, R.V.; Shivateja, K.; Reddy, A.A. Autogenous bone ring transplant vs autologous growth factor-enriched bone graft matrix in extraction sockets with deficient buccal bone: A comparative clinical study. Int. J. Oral Maxillofac. Implants, 2019, 34(6), 1424-1433.
[http://dx.doi.org/10.11607/jomi.7614] [PMID: 31532824]
[25]
Joshi, C.P.; D’Lima, C.B.; Karde, P.A.; Mamajiwala, A.S. Ridge augmentation using sticky bone: A combination of human tooth allograft and autologous fibrin glue. J. Indian Soc. Periodontol., 2019, 23(5), 493-496.
[PMID: 31543625]
[26]
Sureshbabu, N.M.; Ranganath, A.; Jacob, B. Concentrated growth factor - surgical management of large periapical lesion using a novel platelet concentrate in combination with bone graft. Ann. Maxillofac. Surg., 2020, 10(1), 246-250.
[http://dx.doi.org/10.4103/ams.ams_80_19] [PMID: 32855951]
[27]
Soni, R.; Priya, A.; Yadav, H.; Mishra, N.; Kumar, L. Bone augmentation with sticky bone and platelet-rich fibrin by ridge-split technique and nasal floor engagement for immediate loading of dental implant after extracting impacted canine. Natl. J. Maxillofac. Surg., 2019, 10(1), 98-101.
[http://dx.doi.org/10.4103/njms.NJMS_37_18] [PMID: 31205397]
[28]
Shah, R.; Gowda, T.M.; Thomas, R.; Kumar, T.; Mehta, D.S. Biological activation of bone grafts using injectable platelet-rich fibrin. J. Prosthet. Dent., 2019, 121(3), 391-393.
[http://dx.doi.org/10.1016/j.prosdent.2018.03.027] [PMID: 30409723]
[29]
Shukla, S.; Chug, A.; Mahesh, L.; Singh, S.; Singh, K. Optimal management of intrabony defects: current insights. Clin. Cosmet. Investig. Dent., 2019, 11, 19-25.
[http://dx.doi.org/10.2147/CCIDE.S166164] [PMID: 30697083]
[30]
Cortellini, S.; Castro, A.B.; Temmerman, A.; Van Dessel, J.; Pinto, N.; Jacobs, R.; Quirynen, M. Leucocyte- and platelet-rich fibrin block for bone augmentation procedure: A proof-of-concept study. J. Clin. Periodontol., 2018, 45(5), 624-634.
[http://dx.doi.org/10.1111/jcpe.12877] [PMID: 29421855]
[31]
Andrade, C.; Camino, J.; Nally, M.; Quirynen, M.; Martínez, B.; Pinto, N. Combining autologous particulate dentin, L-PRF, and fibrinogen to create a matrix for predictable ridge preservation: a pilot clinical study. Clin. Oral Investig., 2020, 24(3), 1151-1160.
[http://dx.doi.org/10.1007/s00784-019-02922-z] [PMID: 31292776]
[32]
Miron, R.J.; Zhang, Y. Autologous liquid platelet rich fibrin: A novel drug delivery system. Acta Biomater., 2018, 75, 35-51.
[http://dx.doi.org/10.1016/j.actbio.2018.05.021] [PMID: 29772345]
[33]
Rafiee, A.; Memarpour, M.; Taghvamanesh, S.; Karami, F.; Karami, S.; Morowvat, M.H. Drug delivery assessment of a novel triple antibi-otic-eluting injectable platelet-rich fibrin scaffold: An in-vitro study. Curr. Pharm. Biotechnol., 2021, 22(3), 380-388.
[http://dx.doi.org/10.2174/1389201021666200605110250] [PMID: 32503405]
[34]
Miron, R.J.; Chai, J.; Zheng, S.; Feng, M.; Sculean, A.; Zhang, Y. A novel method for evaluating and quantifying cell types in platelet rich fibrin and an introduction to horizontal centrifugation. J. Biomed. Mater. Res. A, 2019, 107(10), 2257-2271.
[http://dx.doi.org/10.1002/jbm.a.36734] [PMID: 31148358]
[35]
Wang, X.; Zhang, Y.; Choukroun, J.; Ghanaati, S.; Miron, R.J. Effects of an injectable platelet-rich fibrin on osteoblast behavior and bone tissue formation in comparison to platelet-rich plasma. Platelets, 2018, 29(1), 48-55.
[http://dx.doi.org/10.1080/09537104.2017.1293807] [PMID: 28351189]
[36]
Kyyak, S.; Blatt, S.; Pabst, A.; Thiem, D.; Al-Nawas, B.; Kämmerer, P.W. Combination of an allogenic and a xenogenic bone substitute material with injectable platelet-rich fibrin - a comparative in vitro study. J. Biomater. Appl., 2020, 35(1), 83-96.
[http://dx.doi.org/10.1177/0885328220914407] [PMID: 32237950]
[37]
Dohle, E.; El Bagdadi, K.; Sader, R.; Choukroun, J.; James Kirkpatrick, C.; Ghanaati, S. Platelet-rich fibrin-based matrices to improve an-giogenesis in an in vitro co-culture model for bone tissue engineering. J. Tissue Eng. Regen. Med., 2018, 12(3), 598-610.
[http://dx.doi.org/10.1002/term.2475] [PMID: 28509340]
[38]
Chai, J.; Jin, R.; Yuan, G.; Kanter, V.; Miron, R.J.; Zhang, Y. Effect of liquid platelet-rich fibrin and platelet-rich plasma on the regenera-tive potential of dental pulp cells cultured under inflammatory conditions: a comparative analysis. J. Endod., 2019, 45(8), 1000-1008.
[http://dx.doi.org/10.1016/j.joen.2019.04.002] [PMID: 31248700]
[39]
Wang, X.; Zhang, Y.; Choukroun, J.; Ghanaati, S.; Miron, R.J. Behavior of gingival fibroblasts on titanium implant surfaces in combination with either injectable-PRF or PRP. Int. J. Mol. Sci., 2017, 18(2), e331.
[http://dx.doi.org/10.3390/ijms18020331] [PMID: 28165420]
[40]
Wang, X.; Yang, Y.; Zhang, Y.; Miron, R.J. Fluid platelet-rich fibrin stimulates greater dermal skin fibroblast cell migration, proliferation, and collagen synthesis when compared to platelet-rich plasma. J. Cosmet. Dermatol., 2019, 18(6), 2004-2010.
[http://dx.doi.org/10.1111/jocd.12955] [PMID: 30990574]
[41]
Kour, P.; Pudakalkatti, P.S.; Vas, A.M.; Das, S.; Padmanabhan, S. Comparative evaluation of antimicrobial efficacy of platelet-rich plasma, platelet-rich fibrin, and injectable platelet-rich fibrin on the standard strains of Porphyromonas gingivalis and Aggregatibacter actinomy-cetemcomitans. Contemp. Clin. Dent., 2018, 9(Suppl. 2), S325-S330.
[http://dx.doi.org/10.4103/ccd.ccd_367_18] [PMID: 30294166]
[42]
Jasmine, S.; A, T.; Janarthanan, K.; Krishnamoorthy, R.; Alshatwi, A.A. Antimicrobial and antibiofilm potential of injectable platelet rich fibrin-a second-generation platelet concentrate-against biofilm producing oral staphylococcus isolates. Saudi J. Biol. Sci., 2020, 27(1), 41-46.
[http://dx.doi.org/10.1016/j.sjbs.2019.04.012] [PMID: 31889815]
[43]
Aydinyurt, H.S.; Sancak, T.; Taskin, C.; Basbugan, Y.; Akinci, L. Effects of ınjectable platelet-rich fibrin in experimental periodontitis in rats. Odontology, 2021, 109(2), 422-432.
[http://dx.doi.org/10.1007/s10266-020-00557-1] [PMID: 33068206]
[44]
Abd El Raouf, M.; Wang, X.; Miusi, S.; Chai, J. Mohamed AbdEl-Aal, A.B.; Nefissa Helmy, M.M.; Ghanaati, S.; Choukroun, J.; Chouk-roun, E.; Zhang, Y.; Miron, R.J. Injectable-platelet rich fibrin using the low speed centrifugation concept improves cartilage regeneration when compared to platelet-rich plasma. Platelets, 2019, 30(2), 213-221.
[http://dx.doi.org/10.1080/09537104.2017.1401058] [PMID: 29240523]
[45]
Zhang, J.; Yin, C.; Zhao, Q.; Zhao, Z.; Wang, J.; Miron, R.J.; Zhang, Y. Anti-inflammation effects of injectable platelet-rich fibrin via mac-rophages and dendritic cells. J. Biomed. Mater. Res. A, 2020, 108(1), 61-68.
[http://dx.doi.org/10.1002/jbm.a.36792] [PMID: 31449340]
[46]
Kargarpour, Z.; Nasirzade, J.; Panahipour, L.; Miron, R.J.; Gruber, R. Liquid PRF reduces the inflammatory response and osteoclastogene-sis in murine macrophages. Front. Immunol., 2021, 12, 636427.
[http://dx.doi.org/10.3389/fimmu.2021.636427] [PMID: 33897689]
[47]
Shao, Z.; Lyu, C.; Teng, L.; Xie, X.; Sun, J.; Zou, D.; Lu, J. An injectable fibrin scaffold rich in growth factors for skin repair. BioMed Res. Int., 2021, 2021, 8094932
[http://dx.doi.org/10.1155/2021/8094932] [PMID: 33628814]
[48]
İzol, B.S.; Üner, D.D. A new approach for root surface biomodification using injectable platelet-rich fibrin (I-PRF). Med. Sci. Monit., 2019, 25, 4744-4750..
[http://dx.doi.org/10.12659/MSM.915142] [PMID: 31241048]
[49]
Ucak Turer, O.; Ozcan, M.; Alkaya, B.; Surmeli, S.; Seydaoglu, G.; Haytac, M.C. Clinical evaluation of injectable platelet-rich fibrin with connective tissue graft for the treatment of deep gingival recession defects: A controlled randomized clinical trial. J. Clin. Periodontol., 2020, 47(1), 72-80.
[http://dx.doi.org/10.1111/jcpe.13193] [PMID: 31518440]
[50]
Ozsagir, Z.B.; Saglam, E.; Sen Yilmaz, B.; Choukroun, J.; Tunali, M. Injectable platelet-rich fibrin and microneedling for gingival augmen-tation in thin periodontal phenotype: A randomized controlled clinical trial. J. Clin. Periodontol., 2020, 47(4), 489-499.
[http://dx.doi.org/10.1111/jcpe.13247] [PMID: 31912532]
[51]
Gülşen, U.; Dereci, Ö. Evaluation of new bone formation in sinus floor augmentation with injectable platelet-rich fibrin-soaked collagen plug: A pilot study. Implant Dent., 2019, 28(3), 220-225.
[http://dx.doi.org/10.1097/ID.0000000000000883] [PMID: 31124818]
[52]
Gasparro, R.; Adamo, D.; Masucci, M.; Sammartino, G.; Mignogna, M.D. Use of injectable platelet-rich fibrin in the treatment of plasma cell mucositis of the oral cavity refractory to corticosteroid therapy: A case report. Dermatol. Ther. , 2019, 32(5), e13062.
[http://dx.doi.org/10.1111/dth.13062] [PMID: 31415129]
[53]
Gode, S.; Ozturk, A.; Berber, V. Kısmalı, E. Effect of injectable platelet-rich fibrin on diced cartilage’s viability in rhinoplasty. Facial Plast. Surg., 2019, 35(4), 393-396.
[http://dx.doi.org/10.1055/s-0039-1693035] [PMID: 31307095]
[54]
Arora, R.; Shukla, S. Injectable-platelet-rich fibrin-smart blood with stem cells for the treatment of alopecia: A report of three patients. Int. J. Trichology, 2019, 11(3), 128-131.
[http://dx.doi.org/10.4103/ijt.ijt_73_18] [PMID: 31360042]
[55]
Albilia, J.; Herrera-Vizcaíno, C.; Weisleder, H.; Choukroun, J.; Ghanaati, S. Liquid platelet-rich fibrin injections as a treatment adjunct for painful temporomandibular joints: preliminary results. Cranio, 2020, 38(5), 292-304.
[http://dx.doi.org/10.1080/08869634.2018.1516183] [PMID: 30231809]
[56]
Nacopoulos, C.; Vesala, A.M. Lower facial regeneration with a combination of platelet-rich fibrin liquid matrices based on the low speed centrifugation concept-Cleopatra technique. J. Cosmet. Dermatol., 2020, 19(1), 185-189.
[http://dx.doi.org/10.1111/jocd.13196] [PMID: 31674154]
[57]
Giudice, A.; Antonelli, A.; Muraca, D.; Fortunato, L. Usefulness of advanced-platelet rich fibrin (A-PRF) and injectable-platelet rich fibrin (i-PRF) in the management of a massive medication-related osteonecrosis of the jaw (MRONJ): A 5-years follow-up case report. Indian J. Dent. Res., 2020, 31(5), 813-818.
[http://dx.doi.org/10.4103/ijdr.IJDR_689_19] [PMID: 33433526]
[58]
Karadayi, U.; Gursoytrak, B. Randomised controlled trial of arthrocentesis with or without PRF for internal derangement of the TMJ. J. Craniomaxillofac. Surg., 2021, 49(5), 362-367.
[http://dx.doi.org/10.1016/j.jcms.2021.01.018] [PMID: 33581954]
[59]
Mauceri, R.; Murgia, D.; Cicero, O.; Paternò, L.; Fiorillo, L.; De Caro, V.; Campisi, G. Leucocyte- and platelet-rich fibrin block: its use for the treatment of a large cyst with implant-based rehabilitation. Medicina (Kaunas), 2021, 57(2), 180.
[http://dx.doi.org/10.3390/medicina57020180] [PMID: 33672534]
[60]
Shah, R. M G, T.; Thomas, R.; Mehta, D.S. An update on the protocols and biologic actions of platelet rich fibrin in dentistry. Eur. J. Prosthodont. Restor. Dent., 2017, 25(2), 64-72.
[PMID: 28590091]
[61]
Miron, R.J.; Kawase, T.; Dham, A.; Zhang, Y.; Fujioka-Kobayashi, M.; Sculean, A. A technical note on contamination from PRF tubes containing silica and silicone. BMC Oral Health, 2021, 21(1), 135.
[http://dx.doi.org/10.1186/s12903-021-01497-0] [PMID: 33740959]

Rights & Permissions Print Cite
Article Metrics
47
1
© 2024 Bentham Science Publishers | Privacy Policy